The contraction-relaxation coupling of human skeletal muscle with malignant hyperthermia susceptibility.

被引:0
作者
Etchrivi, TS [1 ]
Adnet, P
Haudecoeur, G
Teneur, F
Stix, I
Krivosic-Horber, RM
机构
[1] CHRU, Serv CIVIS, Fac Med, Unite Rech Hyperthermie Maligne,Lab Pharmacol, F-59045 Lille, France
[2] CHU Lille, Hop Roger Salengro, Serv Accueil & Urgences, F-59037 Lille, France
[3] CHU Lille, Hop Roger Salengro, Dept Anesthesie Reanimat Chirurg 2, F-59037 Lille, France
来源
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2002年 / 21卷 / 06期
关键词
malignant hyperthermia; contraction-relaxation coupling;
D O I
10.1016/S0750-7658(02)00668-8
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To assess whether halothane exposure could influence contraction- relaxation coupling of human skeletal muscle with malignant hyperthermia susceptibility. Study designed. Laboratory investigation. Material and methods: Muscle biopsies from 14 patients, including six classified as susceptible to MH (MHS) and eight as classified as non-susceptible (MHN) according to criteria of the European MH group. Mechanical parameters of strips were obtained before and after 3vol% halothane exposure. The contraction and relaxation parameters were measured under isotonic and isometric conditions: maximum shortening and lengthening velocities (respectively maxVc and maxVr); peak of the positive (+ dP/dt(max)) and negative (-dP/dt(max)) twitch tension derivative; ratio R1 = maxVc/ maxVr and ratio R2= (+ dP/dt(max)) (-dP/dt(max)). Results: In MHN muscle, halothane markedly increased maxVc and maxVr, so that the ratio R1 was unchanged. Both + dP/dt(max) and -dP/dt(max) increased such that the ratio R2 did not vary. In MHS muscle, halothane induced a significant decrease in maxVr (p < 0.05) without changes in maxVc, so that the ratio R1 increased significantly. + dP/ dt(max) remained unchanged whereas -dP/dt(max) decreased significantly; the ratio R2 increased (p < 0.05). Conclusion: Our results indicated that, in MHN muscle the contractility property is improved with halothane exposure. In MHS muscle, halothane caused an impairment of relaxation. The mechanical abnormalities observed in this study might be related to sarcoplasmic reticulum dysfunction in MH diseases. (C) 2002 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 25 条
[1]   EFFECTS OF CALCIUM-FREE SOLUTION, CALCIUM-ANTAGONISTS, AND THE CALCIUM AGONIST BAY K-8644 ON MECHANICAL RESPONSES OF SKELETAL-MUSCLE FROM PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA [J].
ADNET, PJ ;
KRIVOSICHORBER, RM ;
ADAMANTIDIS, MM ;
REYFORD, H ;
CORDONNIER, C ;
HAUDECOEUR, G .
ANESTHESIOLOGY, 1991, 75 (03) :413-419
[2]   Effects of veratridine on mechanical responses of human malignant hyperthermic muscle fibers [J].
Adnet, PJ ;
Etchrivi, TS ;
Halle, I ;
Haudecoeur, G ;
Reyford, HG ;
Krivosic-Horber, RM .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1998, 42 (02) :246-253
[4]   DUAL CONTROL OF RELAXATION - ITS ROLE IN THE VENTRICULAR-FUNCTION IN THE MAMMALIAN HEART [J].
BRUTSAERT, DL ;
HOUSMANS, PR ;
GOETHALS, MA .
CIRCULATION RESEARCH, 1980, 47 (05) :637-652
[5]  
CHEMLA D, 1986, AM J PHYSIOL, V250, P1008
[6]   CONTRACTION, RELAXATION, AND ECONOMY OF FORCE GENERATION IN ISOLATED HUMAN DIAPHRAGM MUSCLE [J].
COIRAULT, C ;
RIOU, B ;
BARD, M ;
SUARD, I ;
LECARPENTIER, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (04) :1275-1283
[7]   MECHANICS OF HUMAN QUADRICEPS MUSCLE [J].
COIRAULT, C ;
RIOU, B ;
PERYMAN, N ;
SUARD, I ;
LECARPENTIER, Y .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 77 (04) :1769-1775
[8]  
ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267
[9]   CHANGES IN THE CA-INDUCED CA RELEASE MECHANISM IN THE SARCOPLASMIC-RETICULUM OF THE MUSCLE FROM A PATIENT WITH MALIGNANT HYPERTHERMIA [J].
ENDO, M ;
YAGI, S ;
ISHIZUKA, T ;
HORIUTI, K ;
KOGA, Y ;
AMAHA, K .
BIOMEDICAL RESEARCH-TOKYO, 1983, 4 (01) :83-92
[10]   Shortening velocity of skeletal muscle from humans with malignant hyperthermia susceptibility: effects of halothane [J].
Etchrivi, TS ;
Haudecoeur, G ;
Stix, I ;
Reyford, H ;
Tavernier, B ;
Krivosic-Horber, RM ;
Adnet, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) :107-113